Status:
NOT_YET_RECRUITING
Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients
Lead Sponsor:
Assiut University
Conditions:
Chronic Lymphocytic Leukemia (CLL)
Eligibility:
All Genders
18+ years
Brief Summary
the goal of this study is To describe the clinical, hematologic, and cytogenetic characteristics of CLL cases. The main questions it aims to answer are: 1. what is the impact of cytogenetics abnorma...
Detailed Description
Chronic Lymphocytic Leukemia (CLL) is a CD 5 positive hematological malignancy that is characterized by the excess accumulation of small, mature appearing neoplastic B lymphocytes in the blood, marrow...
Eligibility Criteria
Inclusion
- Age ≥ 18 years newly diagnosed with CLL.
- Adequate diagnostics (flowcytometry and cytogenetics) and follow-up data (at least 1 year).
- Patients giving informed consent.
Exclusion
- Incomplete diagnostics (e.g. flowcytometry of cytogenetics)
- Lost to follow-up within 12 months of diagnosis.
- Refused to give informed consent
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT07162532
Start Date
October 1 2025
End Date
December 1 2026
Last Update
September 9 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.